• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LATS2介导的YAP1磷酸化参与肝癌的肿瘤发生。

LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.

作者信息

Guo Chao, Wang Xintian, Liang Lufeng

机构信息

Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital Changsha 410005, P.R. China.

出版信息

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1690-7. eCollection 2015.

PMID:25973055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4396227/
Abstract

YAP (yes-associated protein) is a transcriptional co-activator that acts downstream of the Hippo signaling pathway and regulates multiple cellular processes, including proliferation and apoptosis. Although YAP plays an important role in various tumors, the underlying mechanism in hepatocellular carcinoma (HCC) tumorigenesis remains unclear. In this study, we observed that the LATS2 was highly expressed in Bel-7402 and HepG2 cell lines, and LATS2 protein level was negatively correlated with YAP1 in HCC cells. And then, we inhibited LATS2 expression by transfecting with siRNA. Western blot and Immunofluorescent staining analysis demonstrated that LATS2 inhibition decreased the dephosphorylation of YAP1 protein and promoted YAP1 nuclear accumulation in HCC cells. Moreover, Immunoprecipitation assay results also indicated that Yap binds directly to TEAD2 and LATS2 inhibition-mediated dephosphorylation increased the YAP1/TEAD2 association, leading to YAP1/TEAD2 transcriptional activation, which in turn upregulated cell invasion in HCC cells. Taken together, our current data indicated a new regulatory mechanism of YAP1 by the LATS2-mediated phosphorylation that was involved in HCC tumorigenesis.

摘要

YAP(Yes相关蛋白)是一种转录共激活因子,作用于Hippo信号通路下游,调节包括增殖和凋亡在内的多种细胞过程。尽管YAP在各种肿瘤中发挥重要作用,但其在肝细胞癌(HCC)肿瘤发生中的潜在机制仍不清楚。在本研究中,我们观察到LATS2在Bel-7402和HepG2细胞系中高表达,且在HCC细胞中LATS2蛋白水平与YAP1呈负相关。然后,我们通过转染siRNA抑制LATS2表达。蛋白质免疫印迹和免疫荧光染色分析表明,抑制LATS2可降低HCC细胞中YAP1蛋白的去磷酸化并促进YAP1核内积累。此外,免疫沉淀试验结果还表明,Yap直接与TEAD2结合,抑制LATS2介导的去磷酸化增加了YAP1/TEAD2的结合,导致YAP1/TEAD2转录激活,进而上调HCC细胞的侵袭能力。综上所述,我们目前的数据表明LATS2介导的磷酸化对YAP1具有一种新的调控机制,该机制参与了HCC的肿瘤发生。

相似文献

1
LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.LATS2介导的YAP1磷酸化参与肝癌的肿瘤发生。
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1690-7. eCollection 2015.
2
Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.阻断新型 MAP4K4-LATS2-SASH1-YAP1 级联反应抑制腔面型乳腺癌的肿瘤发生和转移。
J Biol Chem. 2024 Jun;300(6):107309. doi: 10.1016/j.jbc.2024.107309. Epub 2024 Apr 22.
3
RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.RASAL2 通过 hippo 信号通路的 LATS2/YAP1 轴促进结直肠癌的肿瘤进展。
Mol Cancer. 2018 Jul 23;17(1):102. doi: 10.1186/s12943-018-0853-6.
4
The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.Hippo-YAP信号通路中LATS2激酶调控的表征
Cell Signal. 2016 May;28(5):488-497. doi: 10.1016/j.cellsig.2016.02.012. Epub 2016 Feb 18.
5
The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.Hippo 激酶 LATS2 控制幽门螺杆菌诱导的胃黏膜上皮-间充质转化和肠化生。
Cell Mol Gastroenterol Hepatol. 2020;9(2):257-276. doi: 10.1016/j.jcmgh.2019.10.007. Epub 2019 Oct 24.
6
MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.miR-92 通过 LATS2/YAP1/PD-L1 通路过表达抑制卵巢癌细胞免疫功能。
Clin Transl Oncol. 2021 Mar;23(3):450-458. doi: 10.1007/s12094-020-02439-y. Epub 2020 Jul 11.
7
WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.WWC2 是一个独立的预后因素,并通过 Hippo 信号通路防止肝癌的侵袭。
J Cell Mol Med. 2017 Dec;21(12):3718-3729. doi: 10.1111/jcmm.13281. Epub 2017 Aug 16.
8
RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.RASSF1A 通过 Hippo 通路调控肝细胞癌中 AREG 的表达。
Mol Cancer Res. 2013 Jul;11(7):748-58. doi: 10.1158/1541-7786.MCR-12-0665. Epub 2013 Apr 17.
9
Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.β-连环蛋白和 Yap1 在人肝癌中的激活及在小鼠中诱导肝癌发生。
Gastroenterology. 2014 Sep;147(3):690-701. doi: 10.1053/j.gastro.2014.05.004. Epub 2014 May 14.
10
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.YAP1在体外和体内均可增强胃癌细胞的增殖、迁移和侵袭能力。
Oncotarget. 2016 Dec 6;7(49):81062-81076. doi: 10.18632/oncotarget.13188.

引用本文的文献

1
Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review).靶向肝细胞癌中的 Hippo/YAP1 信号通路:从机制到治疗药物(综述)。
Int J Oncol. 2024 Sep;65(3). doi: 10.3892/ijo.2024.5676. Epub 2024 Aug 2.
2
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.大肿瘤抑制因子 2 是结直肠癌的预后生物标志物,并与免疫浸润相关。
Bioengineered. 2021 Dec;12(2):11648-11661. doi: 10.1080/21655979.2021.1996513.
3
Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma.经导管动脉化疗栓塞联合 Hippo/YAP 抑制显著改善移植性肝癌大鼠的生存。
Lipids Health Dis. 2021 Jul 25;20(1):74. doi: 10.1186/s12944-021-01486-w.
4
lncRNA Promotes Metastasis of Non-Small Cell Lung Cancer Through EZH2-Mediated Activation of Hippo/NOTCH1 Signaling Pathways.长链非编码RNA通过EZH2介导的Hippo/NOTCH1信号通路激活促进非小细胞肺癌转移。
Cell J. 2021 Apr;23(1):21-31. doi: 10.22074/cellj.2021.7010. Epub 2021 Mar 1.
5
Long non‑coding RNA suppresses ovarian cancer progression by regulating Hippo/YAP signaling.长链非编码 RNA 通过调控 Hippo/YAP 信号通路抑制卵巢癌细胞的进展。
Int J Mol Med. 2021 Apr;47(4). doi: 10.3892/ijmm.2021.4877. Epub 2021 Feb 12.
6
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.微小 RNA 在卵巢上皮性癌转移中的作用。
Int J Mol Sci. 2020 Sep 25;21(19):7093. doi: 10.3390/ijms21197093.
7
LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.长链非编码 RNA CRNDE 促进 CELF2 和 LATS2 的表观遗传抑制,从而促进肝癌的增殖、迁移和化疗耐药性。
Cell Death Dis. 2020 Aug 11;11(8):676. doi: 10.1038/s41419-020-02853-8.
8
The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.新型长链非编码RNA LATS2-AS1-001通过与EZH2结合调控LATS2/YAP1信号通路来抑制胃癌进展。
Cancer Cell Int. 2020 May 29;20:204. doi: 10.1186/s12935-020-01285-w. eCollection 2020.
9
TEAD2 as a novel prognostic factor for hepatocellular carcinoma.TEAD2 作为肝细胞癌的一个新的预后因素。
Oncol Rep. 2020 Jun;43(6):1785-1796. doi: 10.3892/or.2020.7578. Epub 2020 Apr 6.
10
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p.人类新基因LNC-HC通过隔离hsa-miR-183-5p抑制肝癌细胞增殖。
Mol Ther Nucleic Acids. 2020 Jun 5;20:468-479. doi: 10.1016/j.omtn.2020.03.008. Epub 2020 Mar 20.

本文引用的文献

1
MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.微小 RNA-181b 通过靶向 LATS2 促进卵巢癌细胞生长和侵袭。
Biochem Biophys Res Commun. 2014 May 9;447(3):446-51. doi: 10.1016/j.bbrc.2014.04.027. Epub 2014 Apr 13.
2
LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.LATS2 通过破坏β-catenin/BCL9 相互作用来抑制致癌 Wnt 信号。
Cell Rep. 2013 Dec 26;5(6):1650-63. doi: 10.1016/j.celrep.2013.11.037. Epub 2013 Dec 19.
3
Control of the hippo pathway by Set7-dependent methylation of Yap.通过 Set7 依赖性甲基化 Yap 来控制 hippo 通路。
Dev Cell. 2013 Jul 29;26(2):188-94. doi: 10.1016/j.devcel.2013.05.025. Epub 2013 Jul 11.
4
YAP/TEAD-mediated transcription controls cellular senescence.YAP/TEAD 介导的转录控制细胞衰老。
Cancer Res. 2013 Jun 15;73(12):3615-24. doi: 10.1158/0008-5472.CAN-12-3793. Epub 2013 Apr 10.
5
The Hippo pathway: regulators and regulations.Hippo 通路:调控因子及其调控机制。
Genes Dev. 2013 Feb 15;27(4):355-71. doi: 10.1101/gad.210773.112.
6
The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.RhoA信号通路介导三阴性乳腺癌细胞系中不依赖基质金属蛋白酶-2和基质金属蛋白酶-9的侵袭行为。
J Cell Biochem. 2013 Jun;114(6):1385-94. doi: 10.1002/jcb.24480.
7
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.β-连环蛋白驱动的癌症需要 YAP1 转录复合物来维持生存和促进肿瘤发生。
Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13.
8
Yes-associated protein is not an independent prognostic marker in breast cancer.Yes 相关蛋白不是乳腺癌的独立预后标志物。
Anticancer Res. 2012 Aug;32(8):3321-5.
9
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.遗传和药理学破坏 TEAD-YAP 复合物可抑制 YAP 的致癌活性。
Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7.
10
Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.Yes 相关蛋白 1 在脑膜瘤中被激活并发挥癌基因作用。
Mol Cancer Res. 2012 Jul;10(7):904-13. doi: 10.1158/1541-7786.MCR-12-0116. Epub 2012 May 22.